TD Cowen Maintains Outperform on Insulet, Lowers Price Target to $300
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Josh Jennings has maintained an 'Outperform' rating on Insulet (NASDAQ:PODD), but lowered the price target from $350 to $300.
August 09, 2023 | 7:58 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Insulet's price target has been lowered from $350 to $300 by TD Cowen, though the 'Outperform' rating is maintained.
The lowering of the price target by TD Cowen could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Outperform' rating indicates that the analyst still sees potential in the stock, which could counterbalance the negative sentiment to some extent.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100